The disadvantages of high flexible endo-ureteral stents (DJ) in case of tum
orinduced extrinsic ureteral compression are due to an insufficient Vertica
l stability of the used stents leading to stent-compression and consecutive
hydro- or pyonephrosis. The new developed tumor-stent used in case of tumo
r-induced ureteral compression is available from 6 to 8 French in diameter
and 24 to 32 cm in length. The corpus consists of a combination of high-sta
bility plastics but is of sufficient elasticity in length. Both ends consis
t of extremely elastic J-parts guaranteeing an exact fixation. As against c
ommon DJ's with the same outside-diameter the new stent has a comparable in
terior diameter and compared to used "old" tumor stents promises a higher i
nterior flow in case of extrinsic diseases. The application can be undertak
en in well-known technique, needs no special instrumentation and no learnin
g-curve. To date 52 stents at our urologic departments were placed without
any problems, the latest remaining for 15 months. Tumor-induced compression
or a higher rate of encrustation could not be seen. All patients tolerated
these stents well. In our opinion the new stabilized endoureteral stent ca
n be seen as a better solution instead of percutaneous nephrostomy or frequ
ent stent changing in patients with tumor induced extrinsic ureteral compre
ssion.